Skip to main content

This section of the IDEAYA Biosciences InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  IDEAYA Biosciences assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQIDYA
Beta0.81
Shares Outstanding74.6M
Average Volume (10 days)787.3K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.97)
Sales (TTM)$0.05
Book Value (MRQ)$8.33
Cash Flow (TTM)($1.55)
Cash (MRQ)$8.02

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy11
 
Buy1
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Michael Anthony White
Chief Scientific Officer
140,000
Acquire
Mar 1, 2024
Briseno Andres Ruiz
See Remarks
85,000
Acquire
Mar 1, 2024
Beaupre Darrin
Chief Medical Officer
160,000
Acquire
Mar 1, 2024
Throne Jason
Chief Legal Officer
125,500
Acquire
Mar 1, 2024
Briseno Andres Ruiz
See Remarks
(2,000)
Sell
Feb 9, 2024

Recent SEC Filings

Company Events
Mar 12, 2024
Insider Buy/Sell
Mar 4, 2024
Insider Buy/Sell
Mar 4, 2024
Insider Buy/Sell
Mar 4, 2024
Insider Buy/Sell
Mar 4, 2024
Close Menu